Background illustration for clinical trials search

Paid Clinical Trials New Haven

Discover 1,147 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Multi-Site Trial of Tirzepatide for Smoking Cessation

for
Smoking Cessation, Smoking Behaviors
Location: New Haven CT, Chicago IL, Aurora CO, Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 21 - 65

Code: NCT07602699

Phase2, Recruiting
Active & Responsive

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

for
Autosomal Dominant Polycystic Kidney Disease
Location: New Haven CT, New York NY, Boston MA, Bethlehem PA,
Sponsor: Calico Life Sciences LLC

Sex: All

Age: 18 - 55

Code: NCT06902558

Phase2, Recruiting
Active & Responsive

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: New Haven CT, New York NY, Foxborough MA, Boston MA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07412756

Phase3, Recruiting
Active & Responsive

A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)

for
Insomnia
Location: New Haven CT, Providence RI, Marlton NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70

Code: NCT06655883

Phase3, Recruiting
Active & Responsive

Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders

for
Alcohol Use
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21 - 70

Code: NCT03764098

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Systems Investigation of Vaccine Responses in Aging and Frailty

for
Influenza
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21+

Code: NCT05291676

Phase2, Recruiting
Active & Responsive

Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)

for
Substance Use Disorders
Location: New Haven CT, Lexington KY, Dallas TX, Fort Worth TX
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07223398

Recruiting
Active & ResponsiveNew

Sex Differences in E-Cigarette Perception

for
Nicotine Dependence, E-cigarette Use
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21 - 44

Code: NCT07398976

Recruiting
Active & Responsive

SV2A Density Cannabis Use Disorder

for
Cannabis Use Disorder, Healthy
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 70+

Code: NCT05472818

Early_phase1, Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: New Haven CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
Active & Responsive

Cardiovascular Disease Risk in Women With Endometriosis

for
Endometriosis
Location: New Haven CT
Sponsor: Yale University

Sex: Female

Age: 18 - 45

Code: NCT03746535

Early_phase1, Recruiting
Active & Responsive

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

for
Primary Biliary Cholangitis
Location: New Haven CT, Manhasset NY, Boston MA, Cherry Hill NJ,
Sponsor: Ipsen

Sex: All

Age: 0+

Code: NCT06447168

Recruiting
Active & Responsive

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

for
Carcinoma, Non-Small-Cell Lung
Location: New Haven CT, Norwich CT, Valhalla NY, The Bronx NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06623422

Phase3, Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: New Haven CT, Berkeley Heights NJ, Albany NY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase3, Recruiting
Active & Responsive

Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

for
Cancer, Adolescent Cancer, Young Adult Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 13 - 39

Code: NCT07224204

Recruiting
Active & Responsive

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: New Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07237516

Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: North Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase3, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: New Haven CT, Hartford CT, The Bronx NY, New York NY,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: New Haven CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase3, Recruiting
Active & Responsive

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

for
EGFR Inhibitor-associated Rash
Location: New Haven CT, New York NY, Fairfax VA, Gahanna OH,
Sponsor: Azitra Inc.

Sex: All

Age: 18+

Code: NCT06830863

Phase1, Phase2, Recruiting